Morepen Laboratories Limited

rs,

Complex, Bandra (East), Mumbai- 400 051 Symbol: MOREPENLAB BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001 Scrip Code: 500288 Subject: Earnings Presentation (Q2’ FY24) Novemb

5%

2'FY24 performance QUARTERLY HIGHLIGHTS C O N S O L I D A T E D Rs. in crores Rs. in crores ^5% N e t R e v e n u e 403.85 425.01 Q2'FY23 Q2'FY24 JlOREPEN ^34% 388 Profit after Tax 303

34%

s. in crores Rs. in crores ^5% N e t R e v e n u e 403.85 425.01 Q2'FY23 Q2'FY24 JlOREPEN ^34% 388 Profit after Tax 303 259 15.82 21.26 404 Q2FY23 Q2'FY24 H1'FY24 performance HALF YEAR

17%

FY24 performance HALF YEARLY HIGHLIGHTS C O N S O L I D A T E D Rs. in crores Rs. in crores ^17% N e t R e v e n u e 707.17 828.46 H1'FY23 H1'FY24 JlOREPEN ^67% 388 Profit after Tax 303

67%

. in crores Rs. in crores ^17% N e t R e v e n u e 707.17 828.46 H1'FY23 H1'FY24 JlOREPEN ^67% 388 Profit after Tax 303 259 21.45 35.89 404 H1'FY23 H1'FY24 C O N S O L I D A T E D QUA

Rs. 425

I D A T E D QUARTERLY HIGHLIGHTS • Business is on the fast growth with a quarterly revenue of Rs. 425 cr. up 5% in Q2 and 17% on H1. • Domestic revenue at Rs. 280.10 Cr. are up by 26% and 31% for Q2'

Rs. 280.10

growth with a quarterly revenue of Rs. 425 cr. up 5% in Q2 and 17% on H1. • Domestic revenue at Rs. 280.10 Cr. are up by 26% and 31% for Q2'FY24 and H1'FY24 respectively. • In the API Business, exports i

26%

revenue of Rs. 425 cr. up 5% in Q2 and 17% on H1. • Domestic revenue at Rs. 280.10 Cr. are up by 26% and 31% for Q2'FY24 and H1'FY24 respectively. • In the API Business, exports is up by 14% while

31%

of Rs. 425 cr. up 5% in Q2 and 17% on H1. • Domestic revenue at Rs. 280.10 Cr. are up by 26% and 31% for Q2'FY24 and H1'FY24 respectively. • In the API Business, exports is up by 14% while domesti

14%

up by 26% and 31% for Q2'FY24 and H1'FY24 respectively. • In the API Business, exports is up by 14% while domestic business has declined 13% on QoQ basis. • Medical Devices business with an astoun

13%

respectively. • In the API Business, exports is up by 14% while domestic business has declined 13% on QoQ basis. • Medical Devices business with an astounding 41% jump in this quarter and 44% in

41%

e domestic business has declined 13% on QoQ basis. • Medical Devices business with an astounding 41% jump in this quarter and 44% in H1. • • • • Domestic Formulation are up 16% in Q2, and 12%